top of page

Gastrointestinal System

Bile acid sequestrants

Core Principle of Bile Acid Sequestrants
🧷 Bile acid sequestrants are positively charged, non-absorbable polymers that bind negatively charged bile acids in the intestinal lumen, preventing their reabsorption in the terminal ileum.
🧷 This interrupts the enterohepatic circulation of bile acids, forcing the liver to synthesize new bile acids from cholesterol via 7α-hydroxylase, thereby depleting hepatic cholesterol stores.
🧷 The liver compensates by upregulating LDL receptors (via SREBP-2 activation), increasing LDL clearance from plasma and lowering serum LDL cholesterol.
🧷 Board pearl: These drugs work entirely in the gut lumen — they are not absorbed systemically, making them safe in pregnancy and children.
Solid White Background
Mechanism of Cholesterol Lowering
📍 Normally, 95% of bile acids are reabsorbed in the terminal ileum and recycled to the liver (enterohepatic circulation).
📍 Sequestrants create an anion exchange resin that irreversibly binds bile acids, forming an insoluble complex excreted in feces.
📍 The liver senses bile acid depletion and upregulates cholesterol 7α-hydroxylase to synthesize new bile acids from cholesterol.
📍 Hepatic cholesterol depletion → SREBP-2 activation → LDL receptor upregulation → increased LDL uptake → decreased plasma LDL.
📍 Board pearl: The entire mechanism depends on intact LDL receptors — these drugs are ineffective in homozygous familial hypercholesterolemia.
Solid White Background
Available Agents and Dosing
🔹 Cholestyramine: oldest agent, 4-24 g/day divided BID-QID as powder mixed with liquid.
🔹 Colestipol: similar to cholestyramine, tablets or granules, 2-16 g/day.
🔹 Colesevelam: newer agent with better tolerability, 3.75 g/day as tablets or powder, can be given once daily.
🔹 All must be taken with meals when bile acids are released — timing with food is critical for efficacy.
🔹 Board distinction: Colesevelam has additional FDA approval for type 2 diabetes (modest A1c reduction ~0.5%) due to effects on glucose metabolism.
Solid White Background
Lipid Effects and Clinical Efficacy
⭐ LDL cholesterol reduction: 15-30% (dose-dependent), maximal effect within 2 weeks.
⭐ HDL cholesterol: modest increase of 3-5%.
⭐ Triglycerides: paradoxically INCREASE by 5-15% — contraindicated if baseline TG >300 mg/dL due to risk of severe hypertriglyceridemia.
⭐ No direct effect on Lp(a) or apoB levels.
⭐ Board pearl: If a patient on a bile acid sequestrant develops worsening hypertriglyceridemia, the drug should be discontinued — this is a known class effect.
Solid White Background
Gastrointestinal Side Effects
✅ Constipation: most common side effect (up to 30% of patients), due to binding of bile acids that normally promote colonic motility.
✅ Bloating, flatulence, and abdominal discomfort: result from altered gut flora and fermentation.
✅ Nausea and dyspepsia: especially with cholestyramine due to gritty texture and fishy odor.
✅ Steatorrhea: rare but can occur with high doses due to impaired fat absorption.
✅ Management tip: Start low and titrate slowly, ensure adequate fluid intake, consider stool softeners prophylactically.
Solid White Background
Drug-Drug Interactions
🧠 Sequestrants can bind numerous medications in the gut, preventing their absorption: digoxin, warfarin, thyroxine, thiazide diuretics, beta-blockers, and fat-soluble vitamins (A, D, E, K).
🧠 Critical timing rule: Other medications should be taken 1 hour before or 4-6 hours after the sequestrant.
🧠 Warfarin interaction is particularly dangerous — can lead to subtherapeutic INR and thrombotic events.
🧠 May reduce absorption of oral contraceptives — alternative contraception should be considered.
🧠 Board pearl: A patient on warfarin with previously stable INR starts cholestyramine and develops DVT → suspect drug interaction.
Solid White Background
Fat-Soluble Vitamin Deficiency
⚡ Bile acids are required for micelle formation and absorption of fat-soluble vitamins (A, D, E, K) in the small intestine.
⚡ Chronic sequestrant use can lead to deficiencies: night blindness (vitamin A), osteomalacia (vitamin D), neuropathy/hemolysis (vitamin E), coagulopathy (vitamin K).
⚡ Risk is highest with high doses and prolonged therapy.
⚡ Vitamin K deficiency → prolonged PT/INR → bleeding risk, especially problematic if patient needs surgery.
⚡ Board pearl: Unexplained bruising in a patient on long-term cholestyramine → check PT/INR for vitamin K deficiency.
Solid White Background
Use in Pruritus of Cholestasis
📌 Bile acid sequestrants are first-line therapy for pruritus in cholestatic liver disease (primary biliary cholangitis, primary sclerosing cholangitis, intrahepatic cholestasis of pregnancy).
📌 Pruritus is caused by bile acid accumulation in skin — sequestrants reduce the bile acid pool available for reabsorption.
📌 Cholestyramine 4 g TID is the standard regimen, with symptom improvement within days.
📌 Board pearl: Pregnant woman with severe itching, elevated bile acids, and transaminitis → intrahepatic cholestasis of pregnancy → cholestyramine is safe and effective.
Solid White Background
Combination Therapy Strategies
📣 Sequestrants + statins: additive LDL lowering (up to 50% total reduction), different mechanisms allow synergy.
📣 Timing is critical: statin should be taken in the evening, sequestrant with breakfast and lunch to avoid interaction.
📣 Sequestrants + ezetimibe: complementary mechanisms (reduced synthesis + reduced absorption).
📣 Avoid combining with fibrates due to opposing effects on triglycerides.
📣 Board pearl: Maximum LDL reduction requires hitting multiple pathways — synthesis (statins), absorption (ezetimibe), and clearance (sequestrants).
Solid White Background
Use in Pediatric Hyperlipidemia
🔸 Bile acid sequestrants are the only lipid-lowering drugs approved for children as young as 10 years (colesevelam).
🔸 First-line pharmacotherapy for heterozygous familial hypercholesterolemia in children after diet fails.
🔸 Safety profile is ideal for pediatrics: no systemic absorption, no effect on growth or development.
🔸 Main challenge is palatability and GI tolerability — colesevelam tablets are better tolerated than powders.
🔸 Board pearl: 12-year-old with LDL 190 mg/dL despite diet, family history of early MI → start colesevelam, not a statin.
Solid White Background
Bile Acid Diarrhea and Sequestrants
🧷 Bile acid malabsorption causes chronic watery diarrhea due to colonic secretion stimulated by excess bile acids.
🧷 Occurs after ileal resection (Crohn's disease), radiation enteritis, or idiopathically.
🧷 Sequestrants bind excess bile acids, preventing colonic irritation and secretory diarrhea.
🧷 SeHCAT test or empiric trial of cholestyramine can establish diagnosis.
🧷 Board pearl: Patient with chronic diarrhea after ileal resection for Crohn's → empiric cholestyramine trial is both diagnostic and therapeutic.
Solid White Background
Metabolic Effects Beyond Lipids
📍 Glucose metabolism: Colesevelam reduces HbA1c by ~0.5% through unclear mechanisms (delayed glucose absorption, incretin effects).
📍 Homocysteine: May increase levels by interfering with folate absorption — relevant for cardiovascular risk.
📍 Thyroid function: Can reduce thyroxine absorption, requiring dose adjustment in hypothyroid patients.
📍 Bile acid sequestration alters FXR and TGR5 signaling with metabolic consequences still being elucidated.
📍 Board pearl: Diabetic patient starts colesevelam for LDL → expect modest improvement in glycemic control as a bonus.
Solid White Background
Contraindications and Precautions
🔹 Absolute contraindications: Complete biliary obstruction (no bile acids to bind), triglycerides >300 mg/dL (risk of pancreatitis from further TG elevation).
🔹 Relative contraindications: Severe constipation, major GI motility disorders, dysphagia (for powder formulations).
🔹 Use with caution in patients on multiple medications due to interaction potential.
🔹 Pregnancy category B (colesevelam) or C (cholestyramine, colestipol) — generally considered safe as not absorbed.
🔹 Board pearl: Patient with triglycerides 450 mg/dL should NOT receive bile acid sequestrants — will worsen hypertriglyceridemia.
Solid White Background
Monitoring and Follow-up
⭐ Baseline: Lipid panel including triglycerides, liver enzymes, consider fat-soluble vitamin levels if prolonged use planned.
⭐ Follow-up lipid panel at 6-8 weeks to assess response and check for triglyceride elevation.
⭐ Annual monitoring of fat-soluble vitamins (especially vitamins A, D, K) for patients on chronic therapy.
⭐ Monitor PT/INR more frequently if on warfarin due to dual risk (drug interaction + vitamin K deficiency).
⭐ Board pearl: New-onset bleeding in a patient on chronic cholestyramine → check both PT/INR and medication timing.
Solid White Background
Special Population Considerations
✅ Elderly: Start with lower doses due to increased susceptibility to constipation and drug interactions from polypharmacy.
✅ Pregnancy: Preferred lipid-lowering option when needed (familial hypercholesterolemia) — no systemic absorption.
✅ Chronic kidney disease: Safe option as no renal excretion required, but monitor for hyperchloremic acidosis with high doses.
✅ Liver disease: Useful for pruritus but may worsen fat malabsorption and vitamin deficiencies in advanced cirrhosis.
✅ Post-bariatric surgery: May have altered efficacy due to changed anatomy affecting bile acid circulation.
Solid White Background
Mechanisms of Treatment Failure
🧠 Poor adherence due to GI side effects (most common cause of discontinuation).
🧠 Incorrect timing with meals — must be taken when bile acids are present.
🧠 Compensatory increase in cholesterol synthesis may limit efficacy (combine with statin to block this).
🧠 Underlying triglyceride disorder unmasked by treatment.
🧠 Malabsorption of concurrent medications leading to perceived treatment failure of other conditions.
🧠 Board pearl: Patient with "statin-resistant" hyperlipidemia starts taking cholestyramine 4 hours after their statin → likely drug interaction, not true resistance.
Solid White Background
Cost and Formulary Considerations
⚡ Generic cholestyramine is inexpensive but poorly tolerated.
⚡ Colesevelam is more expensive but has better tolerability and once-daily dosing.
⚡ Insurance coverage varies — may require prior authorization or step therapy through older agents.
⚡ Cost-effectiveness improves in patients who cannot tolerate statins or need add-on therapy.
⚡ For bile acid diarrhea, generic cholestyramine is highly cost-effective compared to anti-diarrheal medications.
Solid White Background
Future Directions and Novel Applications
📌 Research into bile acid sequestrants for NASH/NAFLD through FXR modulation.
📌 Potential role in colorectal cancer prevention through bile acid binding.
📌 Combination products in development to improve adherence.
📌 Novel sequestrants with higher binding capacity and selectivity.
📌 Investigation of metabolic effects beyond lipids — weight loss, inflammation, microbiome modulation.
📌 Targeted sequestrants that bind specific toxic bile acid species while preserving beneficial ones.
Solid White Background
Board Question Stem Patterns
📣 Patient on multiple medications develops subtherapeutic drug levels → suspect timing interaction with bile acid sequestrant.
📣 Severe pruritus in pregnancy with elevated bile acids → cholestyramine for intrahepatic cholestasis of pregnancy.
📣 LDL decreased but triglycerides increased after starting new medication → bile acid sequestrant effect.
📣 Child with familial hypercholesterolemia needs treatment → bile acid sequestrant is first-line pharmacotherapy.
📣 Chronic diarrhea after ileal resection → empiric cholestyramine trial.
📣 Unexplained bleeding in patient on chronic cholestyramine → vitamin K deficiency.
📣 Diabetic with LDL elevation → colesevelam offers dual benefit.
Solid White Background
One-Line Recap
🔸 Bile acid sequestrants are non-absorbed intestinal resins that interrupt enterohepatic circulation of bile acids, forcing hepatic cholesterol consumption for new bile acid synthesis and upregulating LDL receptors to achieve 15-30% LDL reduction, with unique applications in cholestatic pruritus and bile acid diarrhea but limited by GI side effects, drug interactions requiring careful timing, and paradoxical triglyceride elevation.
Solid White Background
bottom of page